ASCO 2025: Most-Viewed AbstractsASCODiscover the top 4 most viewed abstracts at ASCO 2025, including updates on zanidatamab, talazoparib, GFH375, and Ziftomenib across gastric, prostate, solid tumors, and AML research.
PD-(L)1 Resistance HopePD-1Explore how LRRC15+ CAFs contribute to PD-1 resistance, the role of LRRC15 in tumor immunity, and emerging therapies targeting LRRC15 and PD-1 to improve cancer immunotherapy outcomes.
Brain Cancer and Scientific LoveImmunotherapyProfessor Richard Scolyer, a world-leading melanoma expert, bravely pioneered experimental immunotherapy for brain cancer, offering new hope for glioblastoma treatment worldwide.
Top 10 Oncology Products by Global Sales in 2024OncologyExplore the top 10 global oncology drugs of 2024 by sales. Discover leading therapies like Keytruda and Darzalex, modality trends, solid vs. blood tumor market insights, and the growing role of cell and gene therapies.
Top 10 Global Pharmaceutical Giants in Oncology Business for 2024OncologyDiscover the top 10 pharmaceutical giants leading the oncology industry in 2024. From Merck's dominance with Keytruda to AstraZeneca's rise, these companies are making strides in cancer treatment, innovation, and growth.
EN
Agricultural News
Food News
Industrial News
Cosmetic News
Pharmaceutical News
Science News
